Differentiating Uncomplicated and Complicated Urinary Tract Infections (UTIs)

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

October 14th 2025

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

July 24th 2025

Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Group of young adults sitting down | Image credit: Drobot Dean - adobe.stock.com

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Guideline adherence in treating acute lymphoblastic leukemia (ALL) enhances health care resource utilization, especially for adolescent and young adult patients.

CAR T-cell therapy | Image Credit: Funny -stock.adobe.com

October 29th 2025

Innovative Payment Models, Holistic Medicaid Approaches Could Improve GLP-1 Access, Outcomes

Experts at AMCP Nexus 2025 highlighted how real-world data can improve CAR T-cell therapy access and outcomes.

Related Content

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

Innovative payer approaches and holistic support could help expand GLP-1 use and improve obesity care outcomes, experts claimed.

October 14th 2025

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

July 24th 2025

Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes

Guideline adherence in treating acute lymphoblastic leukemia (ALL) enhances health care resource utilization, especially for adolescent and young adult patients.

October 29th 2025